[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355399-105":59,"doc-detail-355399-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","psat1-promotes-nsclc-progression-via-the-de-novo-serine-synthesis-pathway-and-represents-a-therapeutic-vulnerability-research-article","PSAT1 Promotes NSCLC Progression via the De Novo Serine Synthesis Pathway and Represents a Therapeutic Vulnerability - Research Article","","Non-small cell lung cancer (NSCLC) is a malignant disease with high morbidity, mortality, and profound metabolic reprogramming. Enhanced serine synthesis is central to this shift, yet the regulatory role of phosphoserine aminotransferase 1 (PSAT1) among serine synthesis enzymes remains unclear. Using bioinformatics, immunohistochemistry, functional assays, isotope tracing, western blotting, and nude mouse xenografts, the study characterizes PSAT1 expression, downstream pathway effects, and therapeutic implications for NSCLC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/psat1-promotes-nsclc-progression-via-the-de-novo-serine-synthesis-pathway-and-represents-a-therapeutic-vulnerability-research-article/355399/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/psat1-promotes-nsclc-progression-via-the-de-novo-serine-synthesis-pathway-and-represents-a-therapeutic-vulnerability-research-article/355399.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the focus of this study in NSCLC?","Question",{"text":112,"@type":113},"The study investigates how PSAT1 influences NSCLC progression through the de novo serine synthesis pathway and whether it represents a therapeutic vulnerability.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which experimental approaches were used to validate PSAT1’s role?",{"text":117,"@type":113},"The work combines bioinformatics, immunohistochemistry, cell and apoptosis assays (including flow cytometry), isotope tracing, western blot analysis, and nude mouse xenograft models.",{"name":119,"@type":110,"acceptedAnswer":120},"How does PSAT1 knockdown affect NSCLC cells and treatment response?",{"text":121,"@type":113},"PSAT1 knockdown suppresses the de novo serine synthesis pathway, increases reactive oxygen species, activates the mitochondrial apoptotic pathway, and reduces the efficacy of gefitinib-related outcomes; combining PSAT1 knockdown with serine intake inhibition further suppresses progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355399,1790196605,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>PSAT1 Promotes NSCLC Progression via the De Novo Serine Synthesis Pathway and Represents a Therapeutic Vulnerability\u003Cbr>Xijia Zhou  | Min Zhao | Yingshu Cao | Xiangyu Zhou | Ke Wang\u003Cbr>Department of Respiratory and Critical Care Medicine, the Second Hospital of Jilin University, Changchun, China Correspondence: Ke Wang ([wke@jlu.edu.cn](wke@jlu.edu.cn))\u003Cbr>Received: 14 October 2025 | Revised: 14 January 2026 | Accepted: 23 March 2026\u003Cbr>Keywords: apoptosis | de novo serine synthesis pathway | non-small cell lung cancer | PSAT1 | ROS |  |\n| --- | --- |\n| ABSTRACT\u003Cbr>Background: Non-small cell lung cancer (NSCLC) is a malignant tumor characterized by high morbidity and mortality, as well as metabolic reprogramming. Enhanced serine synthesis plays a crucial role in the aberrant metabolism of NSCLC. Among the three key enzymes involved in serine synthesis, phosphoserine aminotransferase 1 (PSAT1) requires further investigation to elucidate its regulatory mechanisms in NSCLC.\u003Cbr>Methods: In this study, we employed bioinformatics analysis, immunohistochemistry, CCK-8 assay, colony formation assay, flow cytometry assay, isotope tracing technique, WB analysis, and nude mouse xenograft models to validate the expression and function of PSAT1 in NSCLC.\u003Cbr>Results: Our results demonstrated that PSAT1 was significantly upregulated in NSCLC cells and contributed to promoting cell proliferation, inhibiting apoptosis, and attenuating the efficacy of gefitinib treatment. Moreover, knockdown of PSAT1 led to inhibition of the de novo serine synthesis pathway (SSP), elevation of reactive oxygen species (ROS) levels, and activation of the mitochondrial apoptotic pathway. Notably, combined knockdown of PSAT1 with exogenous serine intake inhibition synergistically suppressed NSCLC progression.\u003Cbr>Conclusion: Collectively, our findings highlight that PSAT1 serves as a biomarker for metabolic reprogramming in NSCLC and exhibits a close association with disease development and treatment. |  |\n| 1 | Introduction | [3–5] . Therefore, it is imperative to discover novel therapeutic targets for NSCLC. |\n| Lung cancer, the leading cause of cancer-related mortality [1], |  |\n| is classified into two histological subtypes: Non-small-cell lung | Metabolic reprogramming is a hallmark of malignant tumors, |\n| cancer (NSCLC; 82%) and small-cell lung cancer (SCLC; 14%), | and the “Warburg effect” is a well-established mode of meta- |\n| with approximately 3% of cases having unspecified histology [2] . | bolic reprogramming [6, 7] . The “Warburg effect” refers to the |\n| Due to late diagnosis, chemotherapy resistance, and metastasis, | phenomenon in which normal differentiated cells primarily rely |\n| the five-year survival rate for NSCLC patients remains poor | on mitochondrial oxidative phosphorylation for energy supply, |\n| Abbreviations: 1C, one-carbon; 3-PG, 3-phosphoglycerate; GSH, Reduced glutathione; GSSG, Oxidized glutathione disulfide; IHC, Immunohistochemistry; NADP, Nicotinamide adenine dinucleotide phosphate; NADPH, Nicotinamide adenine dinucleotide phosphate hydrogen; NSCLC, Non-small cell lung cancer; PHGDH, 3-phosphoglycerate dehydrogenase; PSAT1, Phosphoserine aminotransferase 1; PSPH, phosphoserine phosphatase; ROS, Reactive oxygen species; SSP, de novo serine synthesis pathway. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. |  |\n\nCancer Medicine, 2026; 15:e71780 1 of 15  \n[https://doi.org/10.1002/cam4.71780](https://doi.org/10.1002/cam4.71780)  \nwhile most tumor cells depend on aerobic glycolysis [8] . One explanation for this phenomenon is that the “Warburg effect”represents a “selfish” metabolic reprogramming of tumor cells, promoting biosynthesis of nucleot","cbCaiktKu7uOgvq1","https://ap.wps.com/l/cbCaiktKu7uOgvq1","pdf",12591102,15,"English","# Introduction\n## Serine synthesis and metabolic reprogramming in NSCLC\n## Therapeutic relevance of targeting metabolic dependencies\n# Methods and validation approach\n## Bioinformatics and experimental assays\n## Xenograft models","[{\"question\":\"What is the focus of this study in NSCLC?\",\"answer\":\"The study investigates how PSAT1 influences NSCLC progression through the de novo serine synthesis pathway and whether it represents a therapeutic vulnerability.\"},{\"question\":\"Which experimental approaches were used to validate PSAT1’s role?\",\"answer\":\"The work combines bioinformatics, immunohistochemistry, cell and apoptosis assays (including flow cytometry), isotope tracing, western blot analysis, and nude mouse xenograft models.\"},{\"question\":\"How does PSAT1 knockdown affect NSCLC cells and treatment response?\",\"answer\":\"PSAT1 knockdown suppresses the de novo serine synthesis pathway, increases reactive oxygen species, activates the mitochondrial apoptotic pathway, and reduces the efficacy of gefitinib-related outcomes; combining PSAT1 knockdown with serine intake inhibition further suppresses progression.\"}]","PSAT1 Promotes NSCLC Progression via the De Novo Serine Synthesis Pathway and Represents a Therapeutic Vulnerability - Research Article | PDF",1790118538,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1b9b296126ae7dffd2e8ef9a76408fc.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8ff582cd9a457ef6fc72666291ce813.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88a1daea44f7aabac5c0a94962ca4fc7.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a0f5ea04c7cb74671f40c25f69f69ab.webp",980,1287]